Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Caris Life Sciences
MedTech
FDA approves Caris multi-cancer companion diagnostic test
The company describes the test as the first of its kind to offer simultaneous whole exome sequencing and whole transcriptome sequencing.
Conor Hale
Nov 13, 2024 9:00am
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
JPM24: Caris crafts collabs with AbbVie, Flatiron Health
Jan 9, 2024 3:34pm
Caris Life Sciences nears $2B in total funding with $400M haul
Jan 19, 2023 4:15pm
Caris teams up with ConcertAI on cancer trial data platforms
Jan 13, 2023 11:33am
ASCO: Caris to launch cancer blood test spanning 22,000 genes
Jun 6, 2022 9:20am
